产品编号 :
Cas No. :
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 1mg | 95% | 询价 | |||
| 5mg | 95% | 询价 | |||
| 10mg | 95% | 询价 | |||
| 25mg | 95% | 询价 | |||
| 50mg | 95% | 询价 | |||
| 100mg | 95% | 询价 |
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 1mg | 95% | 询价 | |||
| 5mg | 95% | 询价 | |||
| 10mg | 95% | 询价 | |||
| 25mg | 95% | 询价 | |||
| 50mg | 95% | 询价 | |||
| 100mg | 95% | 询价 |
CAS No. |
209746-59-8 |
|---|---|
英文名称 |
T-1095 |
别名 |
T-1095;T 1095; T1095;T1095, T 1095, T1095;CS-2245;1-Propanone, 3-(5-benzofuranyl)-1-[2-hydroxy-6-[[6-O-(methoxycarbonyl)-β-D-glucopyranosyl]oxy]-4-methylphenyl]-;[(2R,3S,4S,5R,6S)-6-{2-[3-(1-benzofuran-5-yl)propanoyl]-3-hydroxy-5-methylphenoxy}-3,4,5-trihydroxyoxan-2-yl]methyl methyl carbonate;SGLT1,Sodium-dependent glucose cotransporters,T 1095,antidiabetic,SGLT2,Inhibitor,T1095,T-1095,orally active,SGLT,inhibit;T-1095, 10 mM in DMSO |
标准英文名 |
((2R,3S,4S,5R,6S)-6-(2-(3-(benzofuran-5-yl)propanoyl)-3-hydroxy-5-methylphenoxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)methyl methyl carbonate |
MDL No. |
MFCD28404653 |
分子式 |
C26H28O11 |
分子量 |
516.50 |
精确分子量 |
516.16 |
SMILES |
O=C(OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC2=CC(C)=CC(O)=C2C(CCC3=CC=C(OC=C4)C4=C3)=O)O1)OC |
标准SMILES |
CC1C=C(O[C@@H]2O[C@H](COC(=O)OC)[C@@H](O)[C@H](O)[C@H]2O)C(=C(O)C=1)C(=O)CCC1C=C2C=COC2=CC=1 |
性状 |
White to Yellow Solid |
用途 |
For laboratory research purposes. Not for drug or household use. |
信号词 |
Warning |
InChIKey |
BXNCIERBDJYIQT-PRDVQWLOSA-N |
危险类别(旧) |
H302,H315,H319,H335 |
存储要求 |
Sealed in dry,2-8°C,Keep container tightly closed in a dry and well-ventilated area. Containers which are opened must be carefully resealed and kept upright to prevent leakage. |
危险品分类 |
Acute toxicity, oral (Category 4),Skin corrosion/irritation (Category 2),Serious eye damage/eye irritation (Category 2A),Specific target organ toxicity, single exposure; Respiratory tract irritation (Category 3) |
|---|---|
化学稳定性 |
Stable under recommended storage conditions. |
符号 |
|
|
|
评论 |
|---|